Table 3 Adverse events for both treatments
Adverse events | Â | 3 weeks | Â | Â | 7 weeks | Â | 13 weeks | Â | |
|---|---|---|---|---|---|---|---|---|---|
| Â | MTU | PT | p | MTU | PT | p | MTU | PT | p |
Number | 40 | 31 | 0.1723 | 31 | 23 | 0.1964 | 17 | 12 | 0.3179 |
Severity (NRS) | 4.8 (3.9) | 5.3 (2.6) | 0.3607 | 4.1 (3.1) | 3.8 (2.8) | 0.6456 | 4.9 (3.0) | 3.6 (2.8) | 0.2508 |
Time of onset (n) | |||||||||
 < 30 min. | 4 | 7 |  | 5 | 4 |  | 3 | 0 |  |
 >30 min. < 4 h. | 14 | 7 |  | 5 | 4 |  | 2 | 3 |  |
 > 4 h., < 24 h. | 11 | 8 |  | 11 | 8 |  | 3 | 1 |  |
 > 24 h. | 7 | 6 |  | 5 | 5 |  | 6 | 1 |  |
Duration (n) | |||||||||
 < 10 min. | 0 | 0 |  | 3 | 2 |  | 4 | 1 |  |
 > 10 min., < 1 h. | 4 | 5 |  | 1 | 2 |  | 2 | 0 |  |
 > 1 h., < 24 h. | 13 | 9 |  | 10 | 5 |  | 8 | 3 |  |
 > 24 h. | 20 | 13 |  | 13 | 12 |  | 4 | 2 |  |